Estrella Immunopharma Inc —— 季度财务数据 (NASDAQ:ESLA) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -465.98 K-414.88 K-727.33 K-177.49 K -1.79 M 投资活动产生的现金 ———— — 融资活动产生的现金 -29.46 K1.31 M1.04 M-64.82 K 2.25 M 自由现金流 -465.98 K-414.88 K-727.33 K-177.49 K -1.79 M

新闻

Estrella在淋巴瘤试验中报告100%完全缓解率

Estrella reports 100% complete response rate in lymphoma trial

Estrella将在ASTCT会议上展示CD19靶向细胞疗法的一期数据

Estrella to present phase 1 data on CD19-targeted cell therapy

Estrella Immunopharma收到纳斯达克关于延迟年度股东大会的通知

Estrella Immunopharma receives Nasdaq notice for delayed annual meeting

Estrella Immunopharma完成800万美元注册直接发行

Estrella Immunopharma closes $8 million registered direct offering

Estrella Immunopharma股价在宣布800万美元融资后下跌

Estrella Immunopharma stock falls after announcing $8 million offering

Estrella Immunopharma通过注册发行筹集800万美元资金

Estrella Immunopharma raises $8 million through registered offering